The latest survey data on electronic trial master file (eTMF) usage is from 2018 and puts adoption at 75%. It is no mystery why eTMFs are so popular, they make it easier to track progress, provide more control over a “single source of truth”, and enable better/faster data sharing options than a paper-based process. Digitization is listed as one of the top investments by biotech companies after the pandemic interrupted most in-person study activities. Although there is no data on this yet, I’ll wager that the pandemic has bumped up the adoption of eTMFs quite a bit more. 

In today’s video, we will show how to host eTMFs on the Egnyte for Life Sciences platform and how to facilitate secure data collection and collaboration between external partners. With the addition of our GxP package, our platform gives you the tools to ensure data integrity, meeting 21 CFR Part 11 requirements for the collection and storage of regulated data and documents.

Over 500 life science organizations use Egnyte to collaborate with external partners, manage regulated documents according to GxP standards, and adhere to security and privacy regulations like GDPR and CCPA. From drug research to clinical trials to eTMF archiving, Egnyte for Life Sciences helps Quality, Clinical Development, and IT teams take control of their most valuable asset, their data.

Comments are closed.